ArticleCell death & disease2014

Gefitinib targets ZAP-70-expressing chronic lymphocytic leukemia cells and inhibits B-cell receptor signaling.

R F Dielschneider et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.